Condition
Metastatic Olfactory Neuroblastoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Metastatic Olfactory Neuroblastoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Zanzalintinib for Recurrent or Metastatic Olfactory Neuroblastoma
This study tests whether zanzalintinib can help control recurrent or metastatic olfactory neuroblastoma and whether it is safe.
-
Using enasidenib to treat IDH2-mutated sinonasal and skull base tumors
This study is testing if a new drug called enasidenib can help people with rare nasal or skull base cancers that have a specific mutation and haven't responded to other treatments.
Related topics
Quick answers
How many Metastatic Olfactory Neuroblastoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.